These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2541962)

  • 21. Determination and metabolism of dithiol-chelating agents: electrolytic and chemical reduction of oxidized dithiols in urine.
    Maiorino RM; Barry TJ; Aposhian HV
    Anal Biochem; 1987 Jan; 160(1):217-26. PubMed ID: 3032019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of a lead mobilization test using the chelating agent dimercaptosuccinic acid.
    Hoet P; Buchet JP; Decerf L; Lavalleye B; Haufroid V; Lison D
    Clin Chem; 2006 Jan; 52(1):88-96. PubMed ID: 16239340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urine mercury excretion following meso-dimercaptosuccinic acid challenge in fish eaters.
    Ruha AM; Curry SC; Gerkin RD; Caldwell KL; Osterloh JD; Wax PM
    Arch Pathol Lab Med; 2009 Jan; 133(1):87-92. PubMed ID: 19123743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mobilization of heavy metals by newer, therapeutically useful chelating agents.
    Aposhian HV; Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Dart RC; Aposhian MM
    Toxicology; 1995 Mar; 97(1-3):23-38. PubMed ID: 7716789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lead chelates of meso- and racemic-dimercaptosuccinic acid.
    Rivera M; Aposhian HV; Fernando Q
    J Inorg Biochem; 1989 Dec; 37(4):283-93. PubMed ID: 2560792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial role of monoesters of meso-2,3-dimercaptosuccinic acid in the mobilization of lead and recovery of tissue oxidative injury in rats.
    Saxena G; Pathak U; Flora SJ
    Toxicology; 2005 Oct; 214(1-2):39-56. PubMed ID: 16019123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations.
    Graziano JH; Lolacono NJ; Meyer P
    J Pediatr; 1988 Oct; 113(4):751-7. PubMed ID: 2845043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
    Graziano JH; Siris ES; LoIacono N; Silverberg SJ; Turgeon L
    Clin Pharmacol Ther; 1985 Apr; 37(4):431-8. PubMed ID: 2983924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
    Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
    Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites.
    Lee BK; Schwartz BS; Stewart W; Ahn KD
    Occup Environ Med; 1995 Jan; 52(1):13-9. PubMed ID: 7697134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and properties of the monomethyl ester of meso-dimercaptosuccinic acid and its chelates of lead (II), cadmium(II), and mercury(II).
    Rivera M; Levine DJ; Aposhian HV; Fernando Q
    Chem Res Toxicol; 1991; 4(1):107-14. PubMed ID: 1655086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A study of renal leak of 99mTc-DMSA in maleate-treated rats by factor analysis].
    Koide H; Yonekura Y; Konishi J
    Kaku Igaku; 1990 Feb; 27(2):139-42. PubMed ID: 2161473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
    Bradberry S; Sheehan T; Vale A
    QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arsenic excretion after treatment of arsenic poisoning with DMSA or DMPS in mice.
    Maehashi H; Murata Y
    Jpn J Pharmacol; 1986 Jan; 40(1):188-90. PubMed ID: 3007828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal handling of technetium-99m DMSA in rats with proximal tubular dysfunction.
    Provoost AP; Van Aken M
    J Nucl Med; 1985 Sep; 26(9):1063-7. PubMed ID: 2993552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of meso-2,3-dimercaptosuccinic acid in patients with lead poisoning and in healthy adults.
    Dart RC; Hurlbut KM; Maiorino RM; Mayersohn M; Aposhian HV; Hassen LV
    J Pediatr; 1994 Aug; 125(2):309-16. PubMed ID: 8040783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats.
    Bhadauria S; Flora SJ
    Cell Biol Toxicol; 2007 Mar; 23(2):91-104. PubMed ID: 17086449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans.
    Maiorino RM; Dart RC; Carter DE; Aposhian HV
    J Pharmacol Exp Ther; 1991 Nov; 259(2):808-14. PubMed ID: 1941628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined administration of oxalic acid, succimer and its analogue for the reversal of gallium arsenide-induced oxidative stress in rats.
    Flora SJ; Kannan GM; Pant BP; Jaiswal DK
    Arch Toxicol; 2002 Jun; 76(5-6):269-76. PubMed ID: 12107644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.